The European Prevention of Alzheimer's Dementia Programme: An Innovative Medicines Initiative-funded partnership to facilitate secondary prevention of Alzheimer's disease dementia

INTRODUCTION: Tens of millions of people worldwide will develop Alzheimer's disease (AD), and only by intervening early in the preclinical disease can we make a fundamental difference to the rates of late-stage disease where clinical symptoms and societal burden manifest. However, collectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Saunders, Stina, Gregory, Sarah, Clement, Matthew H. S., Birck, Cindy, van der Geyten, Serge, Ritchie, Craig W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723139/
https://www.ncbi.nlm.nih.gov/pubmed/36484017
http://dx.doi.org/10.3389/fneur.2022.1051543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723139/
https://www.ncbi.nlm.nih.gov/pubmed/36484017
http://dx.doi.org/10.3389/fneur.2022.1051543

Ejemplares similares